501 results on '"Visser, Lydia"'
Search Results
2. A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma
3. Microenvironment, Cross-Talk, and Immune Escape Mechanisms
4. Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma
5. TOX as a new diagnostic marker for T cell large granular lymphocytic leukaemia
6. Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
7. Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
8. Targeting the Microenvironment in Hodgkin Lymphoma: Opportunities and Challenges
9. TOX as a new diagnostic marker for T cell large granular lymphocytic leukaemia.
10. Microenvironment, Cross-Talk, and Immune Escape Mechanisms
11. Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells
12. Toxic Determination of Cry11 Mutated Proteins Obtained Using Rational Design and Its Computational Analysis
13. Microenvironment, Crosstalk, and Immune Escape Mechanisms
14. Supplementary references from Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms
15. Supplementary Table S3 from Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms
16. Supplementary Figure 1 from Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms
17. Long Noncoding RNA Expression Profiling in Normal B-Cell Subsets and Hodgkin Lymphoma Reveals Hodgkin and Reed-Sternberg Cell–Specific Long Noncoding RNAs
18. Tumor Microenvironment Composition Correlates with Quantitative 18F-FDG PET-CT Features and Serum TARC in Patients with Relapsed or Refractory Hodgkin Lymphoma
19. Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma
20. Combined PD-1 and JAK1/2 inhibition in refractory primary mediastinal B-cell lymphoma
21. Microenvironment, Cross-Talk, and Immune Escape Mechanisms
22. Site-Directed Mutants of Parasporin PS2Aa1 with Enhanced Cytotoxic Activity in Colorectal Cancer Cell Lines
23. T001: FDG-PET and serum TARC levels after one cycle of BV-AVD in advanced stage Hodgkin lymphoma patients: results from the very early PET-response adapted EORTC-COBRA trial
24. P031: CD4+ T cells in close proximity to Hodgkin-Reed Sternberg cells are antigen experienced, polyclonal and display an exhausted phenotype
25. Targeting the Microenvironment in Hodgkin Lymphoma: Opportunities and Challenges
26. Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling Pathway
27. Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett’s Esophagus
28. Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP
29. Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin’s lymphoma in vitro
30. CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2
31. The Nature of the Lymphocytes in Hodgkin’s Disease
32. Genetic Modification Approaches for Parasporins Bacillus thuringiensis Proteins with Anticancer Activity
33. Computational study, synthesis and evaluation of active peptides derived from Parasporin-2 and spike protein from Alphacoronavirus against colorectal cancer cells
34. Microenvironment, Crosstalk, and Immune Escape Mechanisms
35. Paediatric nodal marginal zone B-cell lymphadenopathy of the neck: a Haemophilus influenzae-driven immune disorder?
36. Extracellular ligation-dependent CD45RB enzymatic activity negatively regulates lipid raft signal transduction
37. The Role of MicroRNAs in Hodgkin's Lymphoma
38. Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58
39. The CD4+CD26− T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile
40. Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes
41. Somatostatin receptor scintigraphy might be useful for detecting skeleton abnormalities in patients with multiple myeloma and plasmacytoma
42. Soluble PD‐L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma
43. Revised_Supplemental_WEE1i_synergizes_CHOP_and_radiation_TAH – Supplemental material for WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma
44. Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments
45. Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis
46. B Cells as Prognostic Biomarker After Surgery for Colorectal Liver Metastases
47. Strongly enhanced IL-10 production using stable galectin-1 homodimers
48. Interaction between ERAP Alleles and HLA Class I Types Support a Role of Antigen Presentation in Hodgkin Lymphoma Development
49. Microenvironment, Cross-Talk, and Immune Escape Mechanisms
50. Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.